<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

	<!-- RSS feed defaults -->
	<channel>
		<title>Wyss InstituteHealthy Aging &#8211; Wyss Institute</title>
		<link>https://wyss.harvard.edu</link>
		<description>Wyss Institute at Harvard</description>
		<lastBuildDate>Thu, 13 Aug 2026 17:14:49 +0000</lastBuildDate>
		<language>en-US</language>
		<sy:updatePeriod>hourly</sy:updatePeriod>
		<sy:updateFrequency>1</sy:updateFrequency>
		<atom:link href="https://wyss.harvard.edu/application-area/healthy-aging/feed/" rel="self" type="application/rss+xml" />

		<generator>https://wordpress.org/?v=6.9.5</generator>

		<!-- Start loop -->
		
			<item>
				<title>Buying time: A medical breakthrough in stroke treatment</title>
				<link>https://wyss.harvard.edu/media-post/buying-time-a-medical-breakthrough-in-stroke-treatment/</link>
        <pubDate>Wed, 12 Aug 2026 13:33:27 +0000</pubDate>
        <dc:creator><![CDATA[Jessica Leff]]></dc:creator>
        		<category><![CDATA[Brain Health]]></category>
		<category><![CDATA[Donald E. Ingber]]></category>
				<guid isPermaLink="false">https://wyss.harvard.edu/?post_type=media_post&#038;p=45990</guid>
                                                <content:encoded><![CDATA[<p>When a stroke strikes, every minute matters. Science has traditionally approached stroke as a race against time. But rather than racing faster, what if we could instead slow the damage down? Join host Shahni Wellington as she explores groundbreaking research aimed at buying more time for stroke patients, particularly those in rural and regional communities. In this episode, she talks with Dr.</p>
<p><a href="https://wyss.harvard.edu/media-post/buying-time-a-medical-breakthrough-in-stroke-treatment/" rel="nofollow">Source</a></p>]]></content:encoded>
                                    
				<image>
          <link>https://wyss.harvard.edu/media-post/buying-time-a-medical-breakthrough-in-stroke-treatment/</link>
          <title></title>
					<url>https://wyss-prod.imgix.net/app/uploads/2026/08/12093109/LiSTNR_The-Minds-Changing-Lives_App-Square_3000x3000-scaled-e1786541489172.jpg?auto=format%2Ccompress&#038;crop=faces%2Centropy&#038;fit=crop&#038;h=400&#038;q=50&#038;w=300&#038;s=a2300aba390a5577790d4144f35171f6"/></url>
				</image>
        			</item>

		
			<item>
				<title>Harkamal (Hark) Jhajj on rewiring immune cells to repair fractured bones</title>
				<link>https://wyss.harvard.edu/news/humans-of-the-wyss-harkamal-hark-jhajj-on-rewiring-immune-cells-to-repair-fractured-bones/</link>
        <pubDate>Wed, 29 Jul 2026 13:52:41 +0000</pubDate>
        <dc:creator><![CDATA[Jessica Leff]]></dc:creator>
        		<category><![CDATA[Community]]></category>
		<category><![CDATA[Bone]]></category>
		<category><![CDATA[Humans of the Wyss]]></category>
				<guid isPermaLink="false">https://wyss.harvard.edu/?p=45873</guid>
                                                <content:encoded><![CDATA[<p>The Humans of the Wyss (HOW) series features members of the Wyss community discussing their work, the influences that shape them as professionals, and their collaborations at the Wyss Institute and beyond. Harkamal (Hark) Jhajj is always climbing physical and metaphorical mountains. In his spare time, he loves doing physical activities and exploring nature by hiking and visiting national parks.</p>
<p><a href="https://wyss.harvard.edu/news/humans-of-the-wyss-harkamal-hark-jhajj-on-rewiring-immune-cells-to-repair-fractured-bones/" rel="nofollow">Source</a></p>]]></content:encoded>
                                    
				<image>
          <link>https://wyss.harvard.edu/news/humans-of-the-wyss-harkamal-hark-jhajj-on-rewiring-immune-cells-to-repair-fractured-bones/</link>
          <title>Harkamal (Hark) Jhajj, Postdoctoral Fellow. Credit: Wyss Institute at Harvard University</title>
					<url>https://wyss-prod.imgix.net/app/uploads/2026/07/27163442/HoW-Harkamal-Jhajj-Composite-scaled.jpg?auto=format%2Ccompress&#038;crop=faces%2Centropy&#038;fit=crop&#038;h=400&#038;q=50&#038;w=300&#038;s=57f01411fb7d306912a797e9bf730d63"/></url>
				</image>
        			</item>

		
			<item>
				<title>TIB: Tolerance Inducing Biomaterials for Regulatory T Cells</title>
				<link>https://wyss.harvard.edu/technology/tib-tolerance-inducing-biomaterials-for-regulatory-t-cells/</link>
        <pubDate>Mon, 06 Jul 2026 17:38:18 +0000</pubDate>
        <dc:creator><![CDATA[Jessica Leff]]></dc:creator>
        		<category><![CDATA[Autoimmune Diseases]]></category>
		<category><![CDATA[Biomedical Engineering]]></category>
		<category><![CDATA[Bone]]></category>
		<category><![CDATA[Charite]]></category>
		<category><![CDATA[David J. Mooney]]></category>
		<category><![CDATA[Georg Duda]]></category>
		<category><![CDATA[Harvard SEAS]]></category>
		<category><![CDATA[Immune System]]></category>
		<category><![CDATA[Implants]]></category>
		<category><![CDATA[Injectable]]></category>
		<category><![CDATA[Muscle]]></category>
				<guid isPermaLink="false">https://wyss.harvard.edu/?post_type=technology&#038;p=45729</guid>
                                                <content:encoded><![CDATA[<p>Tissue regeneration following injuries and degenerative processes benefits greatly from the activity of regulatory T cells (Tregs) that help balance the immune system, which senses, regulates, and helps restore tissue environments following injury and in disease. In fact, immune therapies using Tregs have shown first promise in treating a wider variety of diseases. However&#8230;</p>
<p><a href="https://wyss.harvard.edu/technology/tib-tolerance-inducing-biomaterials-for-regulatory-t-cells/" rel="nofollow">Source</a></p>]]></content:encoded>
                                    
				<image>
          <link>https://wyss.harvard.edu/technology/tib-tolerance-inducing-biomaterials-for-regulatory-t-cells/</link>
          <title>Envato Elements/LightFieldStudies</title>
					<url>https://wyss-prod.imgix.net/app/uploads/2026/07/06133008/doctor-examines-injured-man-s-arm-at-hospital-2026-03-12-23-51-30-utc-scaled.jpg?auto=format%2Ccompress&#038;crop=faces%2Centropy&#038;fit=crop&#038;h=400&#038;q=50&#038;w=300&#038;s=3d322cec838f5eef0f79c02d234e1f64"/></url>
				</image>
        			</item>

		
			<item>
				<title>The Wyss Institute’s 2026-2027 Validation Projects</title>
				<link>https://wyss.harvard.edu/news/the-wyss-institutes-2026-2027-validation-projects/</link>
        <pubDate>Mon, 06 Jul 2026 14:00:41 +0000</pubDate>
        <dc:creator><![CDATA[Jessica Leff]]></dc:creator>
        		<category><![CDATA[Awards]]></category>
		<category><![CDATA[Community]]></category>
		<category><![CDATA[Research Spotlights]]></category>
		<category><![CDATA[Autoimmune Diseases]]></category>
		<category><![CDATA[Blood]]></category>
		<category><![CDATA[Bone]]></category>
		<category><![CDATA[Endometriosis]]></category>
		<category><![CDATA[Immune System]]></category>
		<category><![CDATA[Technology Translation]]></category>
				<guid isPermaLink="false">https://wyss.harvard.edu/?p=45679</guid>
                            <description>From diagnostics and therapeutics to sustaining life on our planet, 23 Wyss teams are moving promising ideas closer to real-world impact</description>
                                        <content:encoded><![CDATA[<p>Each year, the Wyss Institute&rsquo;s Validation Project program identifies technologies that are ready to move beyond discovery and into the validation phase. Through dedicated funding, technical resources, business development support, market research, and engagement with clinicians, investors, industry experts, and key opinion leaders, the program helps research teams de&#x2d;risk high&#x2d;impact innovations&#8230;</p>
<p><a href="https://wyss.harvard.edu/news/the-wyss-institutes-2026-2027-validation-projects/" rel="nofollow">Source</a></p>]]></content:encoded>
                                    
				<image>
          <link>https://wyss.harvard.edu/news/the-wyss-institutes-2026-2027-validation-projects/</link>
          <title>One Sarah's favorite things about the Wyss is being surrounded by others who are also trying to translate their technologies into companies. Here, she poses with a few of her entrepreneurial friends and colleagues. Credit: Wyss Institute at Harvard University</title>
					<url>https://wyss-prod.imgix.net/app/uploads/2026/06/17153558/Sarah-and-Elizabeth-Candid-Neutral-07507-scaled.jpg?auto=format%2Ccompress&#038;crop=faces%2Centropy&#038;fit=crop&#038;h=400&#038;q=50&#038;w=300&#038;s=bbbb793b3dc71fe4c18d05511384ed06"/></url>
				</image>
        			</item>

		
			<item>
				<title>How federal funds fuel life-saving innovation</title>
				<link>https://wyss.harvard.edu/news/how-federal-funds-fuel-life-saving-innovation/</link>
        <pubDate>Thu, 20 Nov 2025 17:49:40 +0000</pubDate>
        <dc:creator><![CDATA[Jessica Leff]]></dc:creator>
        		<category><![CDATA[Research Spotlights]]></category>
		<category><![CDATA[Translation News]]></category>
		<category><![CDATA[David Paydarfar]]></category>
		<category><![CDATA[Donald E. Ingber]]></category>
		<category><![CDATA[George Church]]></category>
		<category><![CDATA[Technology Translation]]></category>
				<guid isPermaLink="false">https://wyss.harvard.edu/?p=44198</guid>
                            <description>Foundational breakthroughs enabled by government research grants lead to technologies changing patients’ lives for the better</description>
                                        <content:encoded><![CDATA[<p></p>
<p><a href="https://wyss.harvard.edu/news/how-federal-funds-fuel-life-saving-innovation/" rel="nofollow">Source</a></p>]]></content:encoded>
                                    
				<image>
          <link>https://wyss.harvard.edu/news/how-federal-funds-fuel-life-saving-innovation/</link>
          <title>Researchers put a lot of effort into preparing extensive grant applications, which then go through a lengthy review process. A small percentage receive funding. Credit: Wyss Institute at Harvard University</title>
					<url>https://wyss-prod.imgix.net/app/uploads/2025/11/12163644/Kiley-Baker-and-Keysa-Garcia-Candid-Color-Corrected_04289-scaled.jpg?auto=format%2Ccompress&#038;crop=faces%2Centropy&#038;fit=crop&#038;h=400&#038;q=50&#038;w=300&#038;s=93f76f74996be3212132d618d4328d19"/></url>
				</image>
        			</item>

		
			<item>
				<title>Crossing the barrier: Wyss Brain Targeting Program is delivering on its promise</title>
				<link>https://wyss.harvard.edu/news/crossing-the-barrier-wyss-brain-targeting-program-is-delivering-on-its-promise/</link>
        <pubDate>Wed, 22 Oct 2025 13:18:46 +0000</pubDate>
        <dc:creator><![CDATA[Seth Kroll]]></dc:creator>
        		<category><![CDATA[Research Spotlights]]></category>
		<category><![CDATA[Translation News]]></category>
		<category><![CDATA[Brain Health]]></category>
		<category><![CDATA[Brain Targeting Program]]></category>
		<category><![CDATA[Donald E. Ingber]]></category>
				<guid isPermaLink="false">https://wyss.harvard.edu/?p=43961</guid>
                            <description>Collaboration catalyzes industry progress</description>
                                        <content:encoded><![CDATA[<p>By Seth Kroll (BOSTON) &mdash; Launched in 2019 as an ambitious idea, the Wyss Brain Targeting Program was designed to address a critical challenge in neuroscience and brain health: how to safely and effectively deliver drugs across the blood&#x2d;brain barrier (BBB). The BBB is a tightly regulated gateway that protects the brain from toxins and pathogens but also prevents nearly all large&#x2d;molecule drugs&#8230;</p>
<p><a href="https://wyss.harvard.edu/news/crossing-the-barrier-wyss-brain-targeting-program-is-delivering-on-its-promise/" rel="nofollow">Source</a></p>]]></content:encoded>
                                    
				<image>
          <link>https://wyss.harvard.edu/news/crossing-the-barrier-wyss-brain-targeting-program-is-delivering-on-its-promise/</link>
          <title>The Wyss Brain Targeting  team. Credit: Wyss Institute at Harvard University</title>
					<url>https://wyss-prod.imgix.net/app/uploads/2025/10/28095702/BTP-Team-Photo.png?auto=format%2Ccompress&#038;crop=faces%2Centropy&#038;fit=crop&#038;h=400&#038;q=50&#038;w=300&#038;s=0a76c222515163d27fa951a1233a6aaa"/></url>
				</image>
        			</item>

		
			<item>
				<title>GeneSkin: A Novel mRNA Therapy for Skin and Hair Rejuvenation</title>
				<link>https://wyss.harvard.edu/technology/geneskin-a-novel-mrna-therapy-for-skin-and-hair-rejuvenation/</link>
        <pubDate>Thu, 25 Sep 2025 13:44:27 +0000</pubDate>
        <dc:creator><![CDATA[Jessica Leff]]></dc:creator>
        		<category><![CDATA[Anti-aging]]></category>
		<category><![CDATA[George Church]]></category>
		<category><![CDATA[Skin]]></category>
				<guid isPermaLink="false">https://wyss.harvard.edu/?post_type=technology&#038;p=42913</guid>
                                                <content:encoded><![CDATA[<p>More than 1.9 billion people worldwide suffer from some form of skin disease or cosmetic issue, including acne, eczema, scars, wrinkles, and hair loss. However, dermatological research has only brought limited therapeutic progress for skin rejuvenation, scar treatment, and hair loss in recent decades. While many of these conditions share a common root in the declining function of the skin&rsquo;s stem&#8230;</p>
<p><a href="https://wyss.harvard.edu/technology/geneskin-a-novel-mrna-therapy-for-skin-and-hair-rejuvenation/" rel="nofollow">Source</a></p>]]></content:encoded>
                                    
				<image>
          <link>https://wyss.harvard.edu/technology/geneskin-a-novel-mrna-therapy-for-skin-and-hair-rejuvenation/</link>
          <title>Credit: Envato/BLACKDAY</title>
					<url>https://wyss-prod.imgix.net/app/uploads/2025/06/03133310/woman-with-a-scar-on-her-shoulder-2024-10-17-15-24-50-utc-scaled.jpg?auto=format%2Ccompress&#038;crop=faces%2Centropy&#038;fit=crop&#038;h=400&#038;q=50&#038;w=300&#038;s=9d046733faaa4609c5bc35b8aaa3c287"/></url>
				</image>
        			</item>

		
			<item>
				<title>Recapitulating egg and sperm development in the dish</title>
				<link>https://wyss.harvard.edu/news/recapitulating-egg-and-sperm-development-in-the-dish/</link>
        <pubDate>Fri, 15 Aug 2025 17:55:46 +0000</pubDate>
        <dc:creator><![CDATA[Jessica Leff]]></dc:creator>
        		<category><![CDATA[Press Releases]]></category>
		<category><![CDATA[Anti-aging]]></category>
		<category><![CDATA[Biomedical Engineering]]></category>
		<category><![CDATA[Cell Engineering]]></category>
		<category><![CDATA[DNA sequencing]]></category>
		<category><![CDATA[Gene Expression]]></category>
		<category><![CDATA[Gene Regulation]]></category>
		<category><![CDATA[George Church]]></category>
		<category><![CDATA[Harvard Medical School]]></category>
				<guid isPermaLink="false">https://wyss.harvard.edu/?p=43314</guid>
                            <description>New stem cell differentiation method is first to induce meiosis, a critical step in egg and sperm cell development, with potential for drug development and future fertility treatments</description>
                                        <content:encoded><![CDATA[<p>By Benjamin Boettner (BOSTON) &mdash; More than one&#x2d;sixth of adults around the world experience infertility in their lifetime. There is a high unmet need not only for increased access to affordable, high&#x2d;quality fertility care for those in need but, importantly, also for new biomedical solutions that can address the root causes of infertility. Some of the earliest causes of infertility go back to&#8230;</p>
<p><a href="https://wyss.harvard.edu/news/recapitulating-egg-and-sperm-development-in-the-dish/" rel="nofollow">Source</a></p>]]></content:encoded>
                                    
				<image>
          <link>https://wyss.harvard.edu/news/recapitulating-egg-and-sperm-development-in-the-dish/</link>
          <title></title>
					<url>https://wyss-prod.imgix.net/app/uploads/2025/07/16122007/Meiotic-features-in-iPSC-derived-cells-induced-to-differentiate-as-eggs-and-sperm_feature.jpg?auto=format%2Ccompress&#038;crop=faces%2Centropy&#038;fit=crop&#038;h=400&#038;q=50&#038;w=300&#038;s=025fe719d7e73d34266007ebf246a369"/></url>
				</image>
        			</item>

		
			<item>
				<title>The Wyss Institute’s 2025-2026 Validation Projects</title>
				<link>https://wyss.harvard.edu/news/the-wyss-institutes-2025-2026-validation-projects/</link>
        <pubDate>Thu, 14 Aug 2025 15:00:53 +0000</pubDate>
        <dc:creator><![CDATA[Jessica Leff]]></dc:creator>
        		<category><![CDATA[Awards]]></category>
		<category><![CDATA[Community]]></category>
		<category><![CDATA[Research Spotlights]]></category>
		<category><![CDATA[Technology Translation]]></category>
				<guid isPermaLink="false">https://wyss.harvard.edu/?p=43463</guid>
                            <description>14 teams supported this year to advance projects with future potential for real-world impact through the Wyss’ technology innovation funnel</description>
                                        <content:encoded><![CDATA[<p>Throughout recent years, the Wyss&rsquo; Validation Project mechanism has proven to be a highly valuable instrument for selecting and kick&#x2d;starting projects with early potential for positive impact on healthcare and the environment. Reaching deep into areas with major unmet needs across the diverse Grand Challenges laid out by the Institute, the newly selected projects are driven by multi&#x2d;talented teams&#8230;</p>
<p><a href="https://wyss.harvard.edu/news/the-wyss-institutes-2025-2026-validation-projects/" rel="nofollow">Source</a></p>]]></content:encoded>
                                    
				<image>
          <link>https://wyss.harvard.edu/news/the-wyss-institutes-2025-2026-validation-projects/</link>
          <title>Senior Scientist Kwasi Adu-Berchie (center) is leading the TIB project team with Core Faculty member David Mooney (left). The team is developing tolerance-inducing biomaterials to offer patients safer, longer-lasting treatments for conditions ranging from autoimmune disease to tissue and bone injury. Credit: Wyss Institute at Harvard University</title>
					<url>https://wyss-prod.imgix.net/app/uploads/2025/08/13101608/Dave-Mooney-Lab-Candid-Lab-Coat-07873-scaled.jpg?auto=format%2Ccompress&#038;crop=faces%2Centropy&#038;fit=crop&#038;h=400&#038;q=50&#038;w=300&#038;s=b0631ddd4c73659862b34b403e537e4f"/></url>
				</image>
        			</item>

		
			<item>
				<title>Translational AI at the Wyss Institute: how artificial intelligence enables patient impact</title>
				<link>https://wyss.harvard.edu/news/translational-ai-at-the-wyss-institute-how-artificial-intelligence-enables-patient-impact/</link>
        <pubDate>Thu, 26 Jun 2025 13:00:39 +0000</pubDate>
        <dc:creator><![CDATA[Seth Kroll]]></dc:creator>
        		<category><![CDATA[Community]]></category>
		<category><![CDATA[Research Spotlights]]></category>
		<category><![CDATA[Anti-aging]]></category>
		<category><![CDATA[Artificial Intelligence]]></category>
		<category><![CDATA[Computation]]></category>
		<category><![CDATA[Machine Learning]]></category>
		<category><![CDATA[Translational AI Catalyst]]></category>
				<guid isPermaLink="false">https://wyss.harvard.edu/?p=43119</guid>
                            <description>New Wyss Catalyst Embraces AI Landscape to Advance Innovation and Collaboration </description>
                                        <content:encoded><![CDATA[<p>By Seth Kroll (BOSTON) &ndash; Artificial intelligence (AI) is rapidly permeating the modern technological landscape. While its rise often sparks debate and caution in broader society, many in the life sciences view AI as a wellspring of opportunity. Researchers and innovators are increasingly eager to harness its potential to accelerate the development of transformative drugs, diagnostics&#8230;</p>
<p><a href="https://wyss.harvard.edu/news/translational-ai-at-the-wyss-institute-how-artificial-intelligence-enables-patient-impact/" rel="nofollow">Source</a></p>]]></content:encoded>
                                    
				<image>
          <link>https://wyss.harvard.edu/news/translational-ai-at-the-wyss-institute-how-artificial-intelligence-enables-patient-impact/</link>
          <title>Wyss Computational Scientist Megan Sperry describes how she is incorporating AI approaches to drive innovation in her work during a panel discussion with Ally Chang, Wyss Business Development Director, Jim Collins, Wyss Core Faculty, Milad Alucozai, Wyss Mentor & Co-Founder of Revalia Bio, Madhuri Roy, Partner at Cooley, Eric Kelsic, CEO & Co-Founder of Dyno Therapeutics, and Alex Sneider, Co-Founder & Head of Corporate Development at Lila Sciences. Credit: Wyss Institute at Harvard University</title>
					<url>https://wyss-prod.imgix.net/app/uploads/2025/06/19152255/Wyss2025_300-scaled-e1750361107680.jpg?auto=format%2Ccompress&#038;crop=faces%2Centropy&#038;fit=crop&#038;h=400&#038;q=50&#038;w=300&#038;s=717333c49be66edaf9e8df7da5e6330a"/></url>
				</image>
        			</item>

			</channel>
</rss>
